Story
Danone Shares Rise After Q3 Sales Beat Driven by Strong Pricing

Danone (DANO) shares rose after the company reported third-quarter sales that surpassed analyst forecasts, driven by significant price increases that compensated for nearly flat volume growth. The results, coupled with the announcement of a share buyback plan, reassured investors despite signs of weakness in North America.
Sales Beat Driven by Pricing Power
The French food and beverage group posted like-for-like sales growth of 4.0% for the third quarter of 2026, exceeding the analyst consensus of 3.7%, according to its latest earnings release. Reported sales reached €7,233 million, a 5.2% increase year-on-year, which was also aided by favorable currency movements.
The growth was almost entirely fueled by pricing, which contributed 3.6 percentage points, well above the roughly 2.7% analysts had anticipated. In contrast, volume and product mix added a modest 0.4%, falling short of the estimated 1.1% and highlighting a continued reliance on price hikes over increased unit sales.
Mixed Regional and Divisional Performance
Performance varied across Danone's business segments and geographies. The company's Specialized Nutrition division was a standout, delivering organic growth of 4.7% that beat estimates. The EMEA region also performed strongly, with like-for-like growth of 3.9% against a 3.0% consensus.
AdHowever, the North American market disappointed, posting 2.4% organic growth, which was significantly below the 3.7% consensus estimate. In response, Danone announced it was appointing new leadership for its U.S. operations. The company also noted that destocking of its Mizone brand in China weighed on overall group volumes.
Investor Takeaways and Capital Returns
For investors, the top-line beat and a new capital return initiative provided a clear positive catalyst. Danone announced its intention to repurchase approximately 3.5 million shares by the end of the year, signaling confidence in its financial position.
While the stronger-than-expected pricing power and share buyback supported the stock's advance, the nature of the sales beat and the shortfall in North America tempered the rally. The market's reaction reflects a balance between the positive headline numbers and the underlying weakness in sales volumes, a key metric for long-term sustainable growth.
Read next
More on Stocks
S4 Capital Cuts 2026 Revenue Forecast as Q3 Decline Accelerates
The digital advertising firm lowered its full-year net revenue guidance after reporting a 7.3% like-for-like decline in the third quarter, citing persistent macroeconomic pressures and cautious client spending.

GSK Shares Fall as Weaker Vaccine Sales and Trimmed Outlook Overshadow Earnings Beat
GSK plc shares declined despite beating third-quarter estimates, as investors focused on a significant drop in vaccine revenue and a tempered full-year profit forecast.

Intertek Q3 Organic Growth Accelerates to 6.4%, Maintains Full-Year Outlook
The quality assurance provider reported accelerated organic revenue growth in the third quarter, driven by strong performance in its Consumer Products and Industry divisions. Despite a decline in its energy business, Intertek reaffirmed its full-year guidance for 2026.

Unilever Shares Decline as Developed Market Weakness Overshadows Sales Beat
Unilever reported third-quarter sales growth that topped analyst forecasts, but shares fell as investors focused on softer performance in developed markets and a weak Foods division.